Brazil's Senate Approves Patent Bill

25 March 1996

Brazil's Senate has approved patent legislation to bring Brazilian legislation into line with World Trade Organization requirements, voting 43-l1 in favor of treating it as urgent. The bill, which permits patents for pharmaceuticals, chemicals and foodstuffs for the first time, now goes to the floor of the Chamber of Deputies for a final vote.

There are two other versions of the bill. Senator Fernando Bezarra's has a pipeline provision making protection retroactive and covering developed but as-yet unmarketed products, while Senator Ney Suassuna's is seen as more nationalistic, and excludes both pipeline protection and patent protection for biogenetic products.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight